latest update:
[RxAtlas]

drug summary · 3 NDC codes

Zepbound 7.5 mg/.5mL

tirzepatide

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 23862NDC codes 3application NDA217806RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nametirzepatide
active ingredientsTIRZEPATIDE
dosage formINJECTION, SOLUTION
routeSUBCUTANEOUS
strength7.5 mg/.5mL
marketing statusNDA
DEA schedulenot reported
application numberNDA217806
ATC codenot reported
RxCUInot reported
manufacturerEli Lilly and Company
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classG-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

NDC codes

3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00002121401—
00002121404—
0002-1214—

Other tirzepatide products

40 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

28 more are listed in the drug product index.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.